These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29899063)

  • 41. A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.
    Koifman G; Shetzer Y; Eizenberger S; Solomon H; Rotkopf R; Molchadsky A; Lonetto G; Goldfinger N; Rotter V
    Cancer Res; 2018 Oct; 78(20):5833-5847. PubMed ID: 30154152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular events in radiation transformation.
    Syljuåsen RG; Krolewski B; Little JB
    Radiat Res; 2001 Jan; 155(1 Pt 2):215-221. PubMed ID: 11121237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.
    Jia Y; Domenico J; Swasey C; Wang M; Gelfand EW; Lucas JJ
    PLoS One; 2014; 9(5):e97448. PubMed ID: 24848372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
    Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
    Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.
    Cui X; Witalison EE; Chumanevich AP; Chumanevich AA; Poudyal D; Subramanian V; Schetter AJ; Harris CC; Thompson PR; Hofseth LJ
    PLoS One; 2013; 8(1):e53791. PubMed ID: 23308284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases.
    Latham KM; Eastman SW; Wong A; Hinds PW
    Mol Cell Biol; 1996 Aug; 16(8):4445-55. PubMed ID: 8754845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.
    Kleiblova P; Shaltiel IA; Benada J; Ševčík J; Pecháčková S; Pohlreich P; Voest EE; Dundr P; Bartek J; Kleibl Z; Medema RH; Macurek L
    J Cell Biol; 2013 May; 201(4):511-21. PubMed ID: 23649806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.
    Burocziova M; Burdova K; Martinikova AS; Kasparek P; Kleiblova P; Danielsen SA; Borecka M; Jenikova G; Janečková L; Pavel J; Zemankova P; Schneiderova M; Schwarzova L; Ticha I; Sun XF; Jiraskova K; Liska V; Vodickova L; Vodicka P; Sedlacek R; Kleibl Z; Lothe RA; Korinek V; Macurek L
    Cell Death Dis; 2019 Oct; 10(11):818. PubMed ID: 31659152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
    Morris M; Hepburn P; Wynford-Thomas D
    Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of Rb family proteins by Cdk6/Ccnd1 in growth plates.
    Komori T
    Cell Cycle; 2013 Jul; 12(14):2161-2. PubMed ID: 23803733
    [No Abstract]   [Full Text] [Related]  

  • 54. [The cooperation between p53 and Ras in tumorigenesis].
    Wei YY; Hou J; Tang WR; Luo Y
    Yi Chuan; 2012 Dec; 34(12):1513-21. PubMed ID: 23262097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclin D mediates tolerance of genome-doubling in cancers with functional p53.
    Crockford A; Zalmas LP; Grönroos E; Dewhurst SM; McGranahan N; Cuomo ME; Encheva V; Snijders AP; Begum J; Purewal S; Cerveira J; Patel H; Renshaw MJ; Swanton C
    Ann Oncol; 2017 Jan; 28(1):149-156. PubMed ID: 28177473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
    Shukla SK; Jha HC; El-Naccache DW; Robertson ES
    Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
    Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
    Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evolution of thymic lymphomas in p53 knockout mice.
    Dudgeon C; Chan C; Kang W; Sun Y; Emerson R; Robins H; Levine AJ
    Genes Dev; 2014 Dec; 28(23):2613-20. PubMed ID: 25452272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome.
    Dai X; Li L; Liu X; Hu W; Yang Y; Bai Z
    G3 (Bethesda); 2014 Nov; 5(1):81-91. PubMed ID: 25425654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.
    Loizou E; Banito A; Livshits G; Ho YJ; Koche RP; Sánchez-Rivera FJ; Mayle A; Chen CC; Kinalis S; Bagger FO; Kastenhuber ER; Durham BH; Lowe SW
    Cancer Discov; 2019 Jul; 9(7):962-979. PubMed ID: 31068365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.